期刊档案 · Medicine-Ophthalmology
Advances in Ophthalmology Practice and Research
ISSN 2667-3762 · Elsevier · United States
Advances in Ophthalmology Practice and Research 中科院新锐版 医学 2区，影响因子 4.5（官网公布），完全开放获取，APC 约 1,600 美元，近 24 个月 72 篇文章投稿到接收中位 98 天，2025 年发文 50 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Advances in Ophthalmology Practice and Research 由 Elsevier 出版，属中科院医学大类。按 OpenAlex 近年发文统计，该刊主要发表 Ophthalmology and Visual Impairment Studies、Glaucoma and retinal disorders、Retinal Diseases and Treatments 等主题的论文，这 3 个主题约占 30.7%，主导子领域为 Ophthalmology、Radiology, Nuclear Medicine and Imaging。（根据 OpenAlex 主题统计与中科院分区数据生成）
Advances in Ophthalmology Practice and Research (AOPR) is an English scientific, online, peer-reviewed, international and fully open-access journal. The Journal will publish clinical and basic research articles in various subspecialties of ophthalmology and related interdisciplinary and translational medicine fields, reporting advanced eye-related technologies. It aims to provide an academic communication platform for ophthalmic clinicians and scientists to promote the development of ophthalmology-related scientific research, to promote the progress of clinical diagnosis and treatment technology in ophthalmology, and ultimately contribute to the improvement of overall health.Our broad scope ensures that the research published in this journal reaches the widest possible audience with an interest in Ophthalmology and related fields. The journal will publish a variety of article types, including original research, review articles, short communications, practice guidelines, opinions, editorials, comments, correspondence, and meeting reports. AOPR intends to cover the topics of interest that include, but are not limited to the following:Clinical research on novel diagnostic techniques, treatment methods and new drugs for ocular diseases.New clinical findings of eye and ocular diseases, rare or unique ocular disorders, epidemiology of ocular diseases.Interdisciplinary research on eye, vision science and clinical application of ophthalmology, such as materials science, computer technology, biomechanics, etc.Translational Research on diagnosis and treatment of eye diseases.Advanced basic research in ocular diseases, eye function and visual science.An official journal of the Second Affiliated Hospital of Zhejiang University, School of Medicine and the Zhejiang University Press.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Medicine-Ophthalmology
主编 Ke Yao出版商官网
编委会国家分布：中国大陆 23 位（约 37%）；主要国家 中国 23、美国 15、德国 5、日本 3、中国香港 2（共 63 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Ophthalmology and Visual Impairment StudiesMedicine10.8%
- Glaucoma and retinal disordersMedicine10.4%
- Retinal Diseases and TreatmentsMedicine9.5%
- Corneal surgery and disordersMedicine7.9%
- Intraocular Surgery and LensesMedicine6.8%
- Ocular Surface and Contact LensMedicine4.3%
- Retinal and Macular SurgeryMedicine4.3%
- Retinal Imaging and AnalysisMedicine4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 眼科学OPHTHALMOLOGY | 2 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 4.5出版商官网 ·
- CiteScore 2026-06
- 6.7LetPub ·
- CiteScore（出版商公布）
- 6.7出版商官网 ·
- SJR 2026-06
- 1.3LetPub ·
- SNIP 2026-06
- 1.67LetPub ·
- h-index
- 20OpenAlex ·
- i10-index
- 39OpenAlex ·
- 两年平均被引
- 4.75OpenAlex ·
- 自引率
- 4.4%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 38LetPub ·
逐年发文量 OpenAlex 统计 · 累计 224 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 36 | 36 | 7 |
| 2025 | 50 | 50 | 193 |
| 2024 | 53 | 53 | 460 |
| 2023 | 28 | 28 | 239 |
| 2022 | 39 | 39 | 486 |
| 2021 | 18 | 18 | 272 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
98 天投稿到接收中位数 · P25–P75 81 天 – 126 天
- 接收到上线
- 中位数 1 天（72 篇）
- 投稿到上线
- 中位数 107 天
- 样本
- 72 篇有投稿与接收日期的文章（窗口内共 85 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 14 WeeksLetPub ·
- 投稿到首次决定
- 2 天出版商官网 ·
- 外审后首次决定
- 36 天出版商官网 ·
- 投稿到接收
- 96 天出版商官网 ·
- 接收到发表
- 1 天出版商官网 ·
- 投稿到发表（期刊自报）
- 约 23 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 1,600 | 有 | CC BY、CC BY-NC-ND | |
| OpenAlex | USD 1,600 / EUR 1,500 / GBP 1,280 / JPY 198,450 | — | — | |
| LetPub | USD 1,600 | 有 | — | |
| 出版商官网 | USD 1,600 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≥ 1 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- Highlights（研究亮点）
- 可选
- 图文摘要
- 可选
接收的文章类型13 种
- commentariesCommentaries: Articles designed to allow experts from across ophthalmology to present their view on a 'hot topic' or emerging field. Comments offer insight and …未说明篇幅
- commentarySubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- editorialSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- letterSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- letters to the editorSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- meta-analysisSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- opinionSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- original research papersOriginal Research Papers: Includes clinical and basic research full length articles未说明篇幅
- perspectiveSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- research paperSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- reviewSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
- review articlesReview Articles: Systematic reviews of research and meta-analyses that may be submitted to the journal or invited by the Editors.未说明篇幅
- systematic reviewSubmissions are divided into the Article Types listed below. Please select the appropriate Article Type to start the submission.Commentaries: Articles designed …未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
团体署名指将文章归属于一个明确且具名的作者群体，须在投稿时于标题页声明。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能与他人或组织存在的、可能不当影响或偏倚其工作的财务和个人关系。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项，建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
该期刊引导作者参阅其开放获取信息页面以了解开放获取选项。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
该期刊采用单盲同行评审，稿件通常至少由两名审稿人进行独立专家评估，录用与否由编辑决定。 模型中文摘要
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按照爱思唯尔文章共享政策共享预印本，共享预印本不计作先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- 出版国家或地区
- United States
- 出版语言
- English
- ISSN
- 2667-3762
- 学会 / 主办单位
- Second Affiliated Hospital of Zhejiang University
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Advances in Ophthalmology Practice and Research 的常见问题
Advances in Ophthalmology Practice and Research 是中科院几区期刊？
2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。
Advances in Ophthalmology Practice and Research 的影响因子是多少？
期刊官网公布的影响因子为 4.5，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 6.7，h-index 为 20。
Advances in Ophthalmology Practice and Research 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）72 篇已发表文章登记的日期，投稿到接收的中位数为 98 天（四分位 81–126 天）；投稿社区反馈的平均审稿速度为约 14 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Advances in Ophthalmology Practice and Research 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：≥ 1 个；参考文献格式：顺序编码制（按引用顺序编号）；Highlights：可选；图文摘要：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Advances in Ophthalmology Practice and Research 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 63 位编委中，中国大陆 23 位（约 37%）；人数最多的国家是 中国（23 位）、美国（15 位）、德国（5 位）。统计按编委会页面列出的机构国家计，仅供参考。
Advances in Ophthalmology Practice and Research 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Advances in Ophthalmology Practice and Research 被 ESCI、Scopus、DOAJ 收录。
Advances in Ophthalmology Practice and Research 是开放获取期刊吗？版面费多少？
Advances in Ophthalmology Practice and Research 为完全开放获取。APC 约 1,600 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。